Innovation Pharmaceuticals
(OTC) IPIX
Innovation Pharmaceuticals Financials at a Glance
Market Cap
$429,800
Revenue (TTM)
$6.00K
Net Income (TTM)
$2.65M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
7.12 (High)
Dividend
$0.00
Beta (Volatility)
7.12 (High)
Price
$0.00
Volume
2,200
Open
$0.00
Price
$0.00
Volume
2,200
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.02
Dividend
$0.00
Beta (Volatility)
7.12 (High)
Price
$0.00
Volume
2,200
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.02
IPIX News
IPIX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Innovation Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
4
CEO
Leo Ehrlich, CPA
Website
www.ipharminc.comHeadquarters
Wakefield, MA 01880, US
IPIX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
-1%
Return on Assets
-42%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
-2.71%
Stock Overview
Market Cap
$429.80K
Shares Outstanding
537.28M
Volume
2.20K
Short Interest
0.00%
Avg. Volume
224.30K
Financials (TTM)
Gross Profit
$373.00K
Operating Income
$3.11M
EBITDA
$2.74M
Operating Cash Flow
$2.11M
Capital Expenditure
$60.00K
Free Cash Flow
$2.17M
Cash & ST Invst.
$1.52M
Total Debt
$725.00K
Innovation Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$88.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$429.80K
N/A
Market Cap/Employee
$107.45K
N/A
Employees
4
N/A
Net Income
$880.00K
+38.4%
EBITDA
$772.00K
+41.5%
Quarterly Fundamentals
Net Cash
$626.00K
-75.1%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$457.00K
-41.9%
Short Term Debt
$238.00K
-47.1%
Return on Assets
-42.14%
N/A
Return on Invested Capital
-1.25%
N/A
Free Cash Flow
$679.00K
+14.6%
Operating Cash Flow
$677.00K
+14.4%